Clinical trial

Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio

NCT05822674

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-01-01

PhaseN/A

Study timeline

Study start (actual)2022-01-01Date precision: day

Registry last updated2023-04-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

Sitagliptin/metformin ( 50/500mg) Oral TabletDRUG

Empagliflozin/metformin(10/500mg) Oral TabletDRUG

Sponsors & collaborators

University of Diyalalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05822674 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.